Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells

Nanoscale Research Letters

Volumn 10, Issue 1, 2015, Pages 1-17

  Gurunathan, Sangiliyandi ^a,b   Jeong, Jae Kyo ^a   Han, Jae Woong ^a   Zhang, Xi Feng ^a   Park, Jung Hyun ^a   Kim, Jin Hoi ^a  

^a Konkuk University   (South Korea)

^b GS Institute of Bio and Nanotechnology   (India)

Author keywords

Cell viability; Helicobacter felis; Helicobacter pylori; Human lung cells; Lung carcinoma cells; Mitochondrial membrane potential; ROS; Silver nanoparticles

Indexed keywords

BIOFILMS; BIOLOGICAL ORGANS; BIOMOLECULES; CELL DEATH; CRYSTAL STRUCTURE; DYNAMIC LIGHT SCATTERING; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MAMMALS; MEDICAL APPLICATIONS; METAL NANOPARTICLES; MITOCHONDRIA; RESPIRATORY SYSTEM; SILVER NANOPARTICLES;

CELL VIABILITY; HELICOBACTER; HELICOBACTER PYLORI; HUMAN LUNG CELLS; LUNG CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL;

SYNTHESIS (CHEMICAL);

ARTEMISIA PRINCEPS; BACTERIA (MICROORGANISMS); HELICOBACTER FELIS; HELICOBACTER PYLORI; MAMMALIA;

EID: 84923652247     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/s11671-015-0747-0     Document Type: Article

References (128)

1. Ju-Nam Y, Lead JR. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications. Science Total Environment. 2008;400:396–414.
2. Nelson DJ, Strano M. Richard Smalley: saving the world with nanotechnology. Nat Nanotechnol. 2006;1:96–7.
3. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176:1–12.
4. Stensberg MC, Wei QS, McLamore ES, Porterfield DM, Wei A, Sepulveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine. 2011;6:879–98.
5. Tran QH, Nguyen VQ, Le AT. Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci: Nanosci Nanotechnol. 2013;4:033001 (20 pp).
6. Abdel-Mohsen AM, Hrdina R, Burgert L, Abdel-Rahman RM, Hasova M, Smejkalova D, et al. Antibacterial activity and cell viability of hyaluronan fiber with silver nanoparticles. Carbohydr Polym. 2013;92:1177–87.
7. Gnanadhas DP, Ben Thomas M, Thomas R, Raichur AM, Chakravortty D. Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother. 2013;57:4945–55.
8. Gurunathan S, Han JW, Kwon DN, Kim JH. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett. 2014;9:373.
9. Gurunathan S, Kalishwaralal K, Vaidyanathan R, Deepak V, Pandian SRK, Muniyandi J, et al. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surfaces B-Biointerfaces. 2009;74:328–35.
10. Kalimuthu K, Babu RS, Venkataraman D, Bilal M, Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surfaces B-Biointerfaces. 2008;65:150–3.
11. Malik MA, O’Brien P, Revaprasadu N. A simple route to the synthesis of core/shell nanoparticles of chalcogenides. Chem Mater. 2002;14:2004–10.
12. Parikh RY, Singh S, Prasad BLV, Patole MS, Sastry M, Shouche YS. Extracellular synthesis of crystalline silver nanoparticles and molecular evidence of silver resistance from Morganella sp.: towards understanding biochemical synthesis mechanism. ChemBioChem. 2008;9:1415–22.
13. Thakkar KN, Mhatre SS, Parikh RY. Biological synthesis of metallic nanoparticles. Nanomedicine-Nanotechnology Biol Med. 2010;6:257–62.
14. Emerich DF, Thanos CG. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol Eng. 2006;23:171–84.
15. Sintubin L, Verstraete W, Boon N. Biologically produced nanosilver: current state and future perspectives. Biotechnol Bioeng. 2012;109:2422–36.
16. Choi Y, Jeong Y, Chung H, Ito E, Hara M, Noh J. Formation of ordered self-assembled monolayers by adsorption of octylthiocyanates on Au(111). Langmuir. 2007;24:91–6.
17. Klaus T, Joerger R, Olsson E, Granqvist CG. Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci U S A. 1999;96:13611–4.
18. Kalishwaralal K, Deepak V, Ram Kumar Pandian S, Kottaisamy M, BarathmaniKanth S, Kartikeyan B, et al. Biosynthesis of silver and gold nanoparticles using Brevibacterium casei. Colloids Surf B: Biointerfaces. 2010;77:257–62.
19. Suresh AK, Pelletier DA, Wang W, Moon JW, Gu B, Mortensen NP, et al. Silver nanocrystallites: biofabrication using Shewanella oneidensis, and an evaluation of their comparative toxicity on gram-negative and gram-positive bacteria. Environ Sci Technol. 2010;44:5210–5.
20. Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B: Biointerfaces. 2003;28:313–8.
21. Fayaz M, Tiwary CS, Kalaichelvan PT, Venkatesan R. Blue orange light emission from biogenic synthesized silver nanoparticles using Trichoderma viride. Colloids Surf B: Biointerfaces. 2010;75:175–8.
22. Shankar SS, Ahmad A, Sastry M. Geranium leaf assisted biosynthesis of silver nanoparticles. Biotechnol Prog. 2003;19:1627–31.
23. Shankar SS, Rai A, Ahmad A, Sastry M. Controlling the optical properties of lemongrass extract synthesized gold nanotriangles and potential application in infrared-absorbing optical coatings. Chem Mater. 2005;17:566–72.
24. Shankar SS, Rai A, Ahmad A, Sastry M. Rapid synthesis of Au, Ag, and bimetallic Au core-Ag shell nanoparticles using Neem (Azadirachta indica) leaf broth. J Colloid Interface Sci. 2004;275:496–502.
25. Chandran SP, Chaudhary M, Pasricha R, Ahmad A, Sastry M. Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol Prog. 2006;22:577–83.
26. Baishya D, Sharma N, Bora R. Green synthesis of silver nanoparticle using Bryophyllum pinnatum (Lam.) and monitoring their antibacterial activities. Scholars Res. Library. 2012;4:2098–104.
27. Raut RW, Lakkakula JR, Kolekar NS, Mendhulkar VD, Kashid SB. Phytosynthesis of silver nanoparticle using Gliricidia sepium (Jacq.). Curr Nanosci. 2009;5:117–22.
28. Gardea-Torresdey JL, Gomez E, Peralta-Videa JR, Parsons JG, Troiani H, Jose-Yacaman M. Alfalfa sprouts: a natural source for the synthesis of silver nanoparticles. Langmuir. 2003;19:1357–61.
29. Das J, Velusamy P. Biogenic synthesis of antifungal silver nanoparticles using aqueous stem extract of banana. Nano Biomed Eng. 2013;5:34–8.
30. Khalil NM, de Mattos AC, Carraro TCMM, Ludwig DB, Mainardes RM. Nanotechnological strategies for the treatment of neglected diseases. Curr Pharm Des. 2013;19:7316–29.
31. Umano K, Hagi Y, Nakahara K, Shoji A, Shibamoto T. Volatile chemicals identified in extracts from leaves of Japanese mugwort (Artemisia princeps Pamp). J Agric Food Chem. 2000;48:3463–9.
32. Kim YS, Lee JH, Kim MN, Lee WG, Kim JO. Volatile flavour compounds from raw mugwort leaves and parched mugwort. J Korean Soc Food Sci Nutr. 1994;23:261–4.
33. Yun KW, Kil BS, Park JS. Identification of naturally occurring, chemicals from Artemis, princeps var, orientalis. Allelopathy J. 1994;1:95–104.
34. Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009;59 Suppl 1:S4–16.
35. Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect. 1995;103 Suppl 8:263–8.
36. Chang AH, Parsonnet J. Role of bacteria in oncogenesis. Clin Microbiol Rev. 2010;23:837−+.
37. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195–206.
38. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207–15.
39. Sukumar UK, Bhushan B, Dubey P, Matai I, Sachdev A, Packirisamy G. Emerging applications of nanoparticles for lung cancer diagnosis and therapy. Int Nano Lett. 2013;3:45.
40. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
41. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol Vitro. 2005;19:975–83.
42. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci. 2006;92:456–63.
43. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005;88:412–9.
44. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Physical Chem B. 2008;112:13608–19.
45. Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85:743–50.
46. Tripathi RM, Rana D, Shrivastav A, Singh RP, Shrivastavd BR. Biogenic synthesis of silver nanoparticles using Saraca indica leaf extract and evaluation of their antibacterial activity. Nano Biomed Eng. 2013;5:50–6.
47. Abdeen S, Rimal Isaac RS, Geo S, Sornalekshmi S, Rose A, Praseetha PK. Evaluation of antimicrobial activity of biosynthesized iron and silver nanoparticles using the fungi Fusarium oxysporum and Actinomycetes sp. On human pathogens. Nano Biomed Eng. 2013;5:39–45.
48. Li C, Wang XS, Chen F, Zhang CL, Zhi X, Wang K, et al. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials. 2013;34:3882–90.
49. Gurunathan S, Raman J, Malek NA, John PA, Vikineswary S. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. Int J Nanomedicine. 2013;8:4399–413.
50. Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett. 2008;179:93–100.
51. AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279–90.
52. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol Vitro. 2009;23:1076–84.
53. Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett. 2009;190:156–62.
54. Gurunathan S, Han JW, Eppakayala V, Dayem AA, Kwon DN, Kim JH. Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells. Nanoscale Res Lett. 2013;8:393.
55. Yonezawa H, Osaki T, Kurata S, Zaman C, Hanawa T, Kamiya S. Assessment of in vitro biofilm formation by Helicobacter pylori. J Gastroenterol Hepatol. 2010;25 Suppl 1:S90–4.
56. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine. 2012;7:5901–14.
57. Shameli K, Ahmad MB, Yunus WM, Ibrahim NA, Gharayebi Y, Sedaghat S. Synthesis of silver/montmorillonite nanocomposites using gamma-irradiation. Int J Nanomedicine. 2010;5:1067–77.
58. Awwad A, Salem N, Abdeen A. Green synthesis of silver nanoparticles using carob leaf extract and its antibacterial activity. Int J Industr Chem. 2013;4:1–6.
59. Mukherjee S, Chowdhury D, Kotcherlakota R, Patra S, Vinothkumar B, Bhadra MP, et al. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics. 2014;4:316–35.
60. Tavitian BA, Nabedryk E, Mäntele W, Breton J. Light-induced Fourier transform infrared (FTIR) spectroscopic investigations of primary reactions in photosystem I and photosystem II. FEBS Lett. 1986;201:151–7.
61. Kong J, Yu S. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochimica Et Biophysica Sinica. 2007;39:549–59.
62. Loo YY, Chieng BW, Nishibuchi M, Radu S. Synthesis of silver nanoparticles by using tea leaf extract from Camellia sinensis. Int J Nanomedicine. 2012;7:4263–7.
63. Singhal G, Bhavesh R, Kasariya K, Sharma AR, Singh RP. Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity. J Nanoparticle Res. 2011;13:2981–8.
64. Macdonald IDG, Smith WE. Orientation of cytochrome c adsorbed on a citrate-reduced silver colloid surface. Langmuir. 1996;12:706–13.
65. Gole A, Dash C, Ramakrishnan V, Sainkar SR, Mandale AB, Rao M, et al. Pepsin-gold colloid conjugates: preparation, characterization, and enzymatic activity. Langmuir. 2001;17:1674–9.
66. Philip D, Unni C. Extracellular biosynthesis of gold and silver nanoparticles using Krishna tulsi (Ocimum sanctum) leaf. Physica E-Low-Dimensional Systems & Nanostructures. 2011;43:1318–22.
67. Bar H, Bhui DK, Sahoo GP, Sarkar P, De SP, Misra A. Green synthesis of silver nanoparticles using latex of Jatropha curcas. Colloids and Surfaces a-Physicochemical and Engineering Aspects. 2009;339:134–9.
68. Pasupuleti VR, Prasad C, Shiekh RA, Balam SK, Narasimhulu G, Reddy CS, et al. Biogenic silver nanoparticles using Rhinacanthus nasutus leaf extract: synthesis, spectral analysis, and antimicrobial studies. Int J Nanomedicine. 2013;8:3355–64.
69. Rupiasih NN, Avinash A, Suresh G, Vidyasagar PB. Green synthesis of silver nanoparticles using latex extract of Thevetia peruviana: a novel approach towards poisonous plant utilization. J Physics: Conference Series. 2013;423:012032.
70. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci. 2006;90:296–303.
71. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2008;101:239–53.
72. Umoren SA, Obot IB, Gasem ZM. Green synthesis and characterization of silver nanoparticles using red apple (Malus domestica) fruit extract at room temperature. J Materials Environmental Sci. 2014;5:907–14.
73. IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
74. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.
75. Haesebrouck F, Pasmans F, Flahou B, Chiers K, Baele M, Meyns T, et al. Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev. 2009;22:202–23. Table of Contents.
76. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95–101.
77. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–7.
78. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm. 2009;6:1388–401.
79. Parashar UK, Kumar V, Bera T, Saxena PS, Nath G, Srivastava SK, et al. Study of mechanism of enhanced antibacterial activity by green synthesis of silver nanoparticles. Nanotechnology. 2011;22:415104.
80. Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, Chen YB. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol. 2010;85:1115–22.
81. Anthony KJP, Murugan M, Gurunathan S. Biosynthesis of silver nanoparticles from the culture supernatant of Bacillus marisflavi and their potential antibacterial activity. J Industrial Engineering Chemistry. 2014;20:1505–10.
82. Hwang IS, Hwang JH, Choi H, Kim KJ, Lee DG. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J Med Microbiol. 2012;61:1719–26.
83. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275:177–82.
84. Su HL, Chou CC, Hung DJ, Lin SH, Pao IC, Lin JH, et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials. 2009;30:5979–87.
85. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108.
86. Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids and Surfaces B-Biointerfaces. 2010;79:340–4.
87. Khan MM, Ansari SA, Amal MI, Lee J, Cho MH. Highly visible light active Ag@TiO2 nanocomposites synthesized using an electrochemically active biofilm: a novel biogenic approach. Nanoscale. 2013;5:4427–35.
88. Masurkar SA, Chaudhari PR, Shidore VB, Kamble SP. Effect of biologically synthesised silver nanoparticles on Staphylococcus aureus biofilm quenching and prevention of biofilm formation. IET Nanobiotechnol. 2012;6:110–4.
89. Martinez-Gutierrez F, Boegli L, Agostinho A, Sanchez EM, Bach H, Ruiz F, et al. Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling. 2013;29:651–60.
90. Ninganagouda S, Rathod V, Singh D, Hiremath J, Singh AK, Mathew J, et al. Growth kinetics and mechanistic action of reactive oxygen species released by silver nanoparticles from Aspergillus niger on Escherichia coli. Biomed Research International. 2014;2014:753419.
91. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52:662–8.
92. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol. 2008;74:2171–8.
93. Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol. 2003;69:4278–81.
94. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346–53.
95. Yamanaka M, Hara K, Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005;71:7589–93.
96. Dwyer DJ, Camacho DM, Kohanski MA, Callura JM, Collins JJ. Antibiotic-induced bacterial cell death exhibits physiological and biochemical hallmarks of apoptosis. Mol Cell. 2012;46:561–72.
97. Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell. 2010;37:311–20.
98. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130:797–810.
99. Morones-Ramirez JR, Winkler JA, Spina CS, Collins JJ. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med. 2013;5:190ra181.
100. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.
101. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306.
102. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–19.
103. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol. 2007;3:91.
104. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell. 2008;135:679–90.
105. Park JH, Kim EJ, Jang HY, Shim H, Lee KK, Jo HJ, et al. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases. Oncol Rep. 2008;20:379–84.
106. Foster KA, Galeffi F, Gerich FJ, Turner DA, Muller M. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol. 2006;79:136–71.
107. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.
108. Sriram MI, Kalishwaralal K, Barathmanikanth S, Gurunathani S. Size-based cytotoxicity of silver nanoparticles in bovine retinal endothelial cells. Nanoscience Methods. 2012;1:56–77.
109. Almofti MR, Ichikawa T, Yamashita K, Terada H, Shinohara Y. Silver ion induces a cyclosporine a-insensitive permeability transition in rat liver mitochondria and release of apoptogenic cytochrome C. J Biochem. 2003;134:43–9.
110. Kim YJ, Yang SI, Ryu JC. Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines. Molecular Cellular Toxicol. 2010;6:119–25.
111. Zhang T, Wang L, Chen Q, Chen C. Cytotoxic potential of silver nanoparticles. Yonsei Med J. 2014;55:283–91.
112. Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briede JJ, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011;32:9810–7.
113. Song XL, Li B, Xu K, Liu J, Ju W, Wang J, et al. Cytotoxicity of water-soluble mPEG-SH-coated silver nanoparticles in HL-7702 cells. Cell Biol Toxicol. 2012;28:225–37.
114. Lee YS, Kim DW, Lee YH, Oh JH, Yoon S, Choi MS, et al. Silver nanoparticles induce apoptosis and G2/M arrest via PKC zeta-dependent signaling in A549 lung cells. Arch Toxicol. 2011;85:1529–40.
115. Choi SJ, Oh JM, Choy JH. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem. 2009;103:463–71.
116. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823–39.
117. Akhtar MJ, Ahamed M, Kumar S, Khan MAM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine. 2012;7:845–57.
118. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Park MR, Kwon DN, et al. Antibacterial activity of dithiothreitol reduced graphene oxide. J Industrial Engineering Chemistry. 2013;19:1280–8.
119. Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett. 2007;168:58–74.
120. Kimata M, Matoba S, Iwai-Kanai E, Nakamura H, Hoshino A, Nakaoka M, et al. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress. Am J Physiology-Heart Circulatory Physiology. 2010;299:H1908–16.
121. Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis. 2007;12:815–33.
122. Han L, Du LB, Kumar A, Jia HY, Liang XJ, Tian Q, et al. Inhibitory effects of trolox-encapsulated chitosan nanoparticles on tert-butylhydroperoxide induced RAW264.7 apoptosis. Biomaterials. 2012;33:8517–28.
123. Govender R, Phulukdaree A, Gengan RM, Anand K, Chuturgoon AA. Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J Nanobiotechnology. 2013;11:5.
124. Hirsch T, Marzo I, Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep. 1997;17:67–76.
125. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001;15:2922–33.
126. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2:2121–34.
127. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6:1794–807.
128. Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv Mater. 2004;16:961−+.